BSX Earnings & Financial Statements
Boston Scientific Corporation
$43.00
-$0.31(-0.72%)
44
Overall
45
Value
20
Tech
68
Quality
Market Cap
$62.77B
Volume
12.90M
52W Range
$41.39 - $105.65
Target Price
$56.93
BSX earnings and financial statements: Boston Scientific Corporation's income statement, balance sheet and cash flow statement, annual and quarterly.
BSX Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $20.07B | $16.75B | $14.24B | $12.68B | $11.89B |
| Cost of revenue | $6.22B | $5.26B | $4.34B | $3.96B | $3.71B |
| Operating income | $3.61B | $2.60B | $2.34B | $1.65B | $1.20B |
| EBITDA | $5.10B | $3.85B | $3.42B | $2.78B | $2.51B |
| Net income | $2.90B | $1.85B | $1.57B | $698.00M | $1.04B |
| EPS (diluted) | $1.94 | $1.25 | $1.07 | $0.45 | $0.69 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $43.67B | $39.40B | $35.14B | $32.47B | $32.23B |
| Total liabilities | $19.20B | $17.39B | $15.61B | $14.90B | $15.61B |
| Shareholders’ equity | $24.23B | $21.77B | $19.28B | $17.57B | $16.62B |
| Cash and equivalents | $1.97B | $414.00M | $865.00M | $928.00M | $1.93B |
| Long-term debt | $11.14B | $8.97B | $8.57B | $8.91B | $8.80B |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $4.53B | $3.44B | $2.50B | $1.53B | $1.87B |
| Capital expenditure | -$876.00M | -$790.00M | -$800.00M | -$612.00M | -$554.00M |
| Free cash flow | $3.66B | $2.65B | $1.79B | $914.00M | $1.32B |
| Dividends paid | - | - | $28.00M | $55.00M | $55.00M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BSX | $43.00 | -0.7% | 12.90M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Boston Scientific Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW